February, 2024

Remove biobanking-drugs
article thumbnail

The biotech improving immunotherapies with AI

Drug Discovery World

Reece A: What are some of the human limitations to current drug discovery research for immunotherapies? Reece A: AI has typically been used to fast-track certain stages of drug discovery and development but NOETIK is using it to tackle fundamental issues in cancer. Can you tell us about this approach?

Genome 52